RU2165413C2 - Аналоги витамина d, способ их получения, фармацевтическая композиция - Google Patents

Аналоги витамина d, способ их получения, фармацевтическая композиция Download PDF

Info

Publication number
RU2165413C2
RU2165413C2 RU98121401/04A RU98121401A RU2165413C2 RU 2165413 C2 RU2165413 C2 RU 2165413C2 RU 98121401/04 A RU98121401/04 A RU 98121401/04A RU 98121401 A RU98121401 A RU 98121401A RU 2165413 C2 RU2165413 C2 RU 2165413C2
Authority
RU
Russia
Prior art keywords
compound
compounds
ether
formula
pet
Prior art date
Application number
RU98121401/04A
Other languages
English (en)
Russian (ru)
Other versions
RU98121401A (ru
Inventor
Клаус Оге Свенсгор Бреттинг
Original Assignee
Лео Фармасьютикал Продактс Лтд. А/С (Левенс Кемиске Фабрик Продукционсактиесельскаб)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лео Фармасьютикал Продактс Лтд. А/С (Левенс Кемиске Фабрик Продукционсактиесельскаб) filed Critical Лео Фармасьютикал Продактс Лтд. А/С (Левенс Кемиске Фабрик Продукционсактиесельскаб)
Publication of RU98121401A publication Critical patent/RU98121401A/ru
Application granted granted Critical
Publication of RU2165413C2 publication Critical patent/RU2165413C2/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • AIDS & HIV (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
RU98121401/04A 1996-06-04 1997-05-15 Аналоги витамина d, способ их получения, фармацевтическая композиция RU2165413C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9611603.3A GB9611603D0 (en) 1996-06-04 1996-06-04 Chemical compounds
GB9611603.3 1996-06-04

Publications (2)

Publication Number Publication Date
RU98121401A RU98121401A (ru) 2000-08-20
RU2165413C2 true RU2165413C2 (ru) 2001-04-20

Family

ID=10794707

Family Applications (1)

Application Number Title Priority Date Filing Date
RU98121401/04A RU2165413C2 (ru) 1996-06-04 1997-05-15 Аналоги витамина d, способ их получения, фармацевтическая композиция

Country Status (17)

Country Link
US (1) US6197982B1 (Direct)
EP (1) EP0906276B1 (Direct)
JP (1) JP2000511894A (Direct)
CN (1) CN1217926C (Direct)
AT (1) ATE221875T1 (Direct)
AU (1) AU714223B2 (Direct)
CZ (1) CZ296255B6 (Direct)
DE (1) DE69714590T2 (Direct)
DK (1) DK0906276T3 (Direct)
ES (1) ES2179343T3 (Direct)
GB (1) GB9611603D0 (Direct)
NZ (1) NZ332237A (Direct)
PL (1) PL186804B1 (Direct)
PT (1) PT906276E (Direct)
RO (1) RO120133B1 (Direct)
RU (1) RU2165413C2 (Direct)
WO (1) WO1997046522A1 (Direct)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2558362C2 (ru) * 2010-10-25 2015-08-10 Тейдзин Фарма Лимитед Производное 23-ин-витамина d3
RU2560677C2 (ru) * 2009-12-22 2015-08-20 Лео Фарма А/С Кожная композиция, включающая аналог витамина d и смесь растворителя и поверхностно-активных веществ
RU2560184C2 (ru) * 2010-01-26 2015-08-20 Ибриженикс Са Новый способ изомеризации конденсированных бициклических структур и получение аналогов витамина d, содержащих эти структуры
RU2837000C2 (ru) * 2018-04-03 2025-03-25 Опко Айэлэнд Глобал Холдингз, Лтд. Применение кальцифедиола у пациентов, перенесших бариатрическую операцию

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090098065A1 (en) * 2000-01-11 2009-04-16 Avikam Harel Composition and methods for the treatment of skin disorders
EP1458678A1 (en) * 2002-11-18 2004-09-22 Teva Pharmaceutical Industries Limited A crystallization method for purification of calcipotriene
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
KR20110113664A (ko) * 2006-08-29 2011-10-17 테바 파마슈티컬 인더스트리즈 리미티드 비타민 ｄ 및 코르티코스테로이드를 포함하는 약학 조성물
US8377913B2 (en) * 2007-11-20 2013-02-19 Abbvie Inc. Vitamin D receptor activators and methods of making
AU2010208323B2 (en) 2009-01-27 2016-03-10 Berg Llc Vitamin D3 and analogs thereof for alleviating side effects associated with chemotherapy
EP2464357B1 (en) 2009-08-14 2019-05-22 Berg LLC Vitamin d3 and analogs thereof for treating alopecia
CN102770121B (zh) * 2009-12-22 2014-10-15 利奥制药有限公司 包含溶剂混合物和维生素d衍生物或类似物的药物组合物
SG10201709894RA (en) 2013-05-29 2018-01-30 Berg Llc Preventing or mitigating chemotherapy induced alopecia using vitamin d
AU2016234990B2 (en) 2015-10-02 2018-12-06 Lg Electronics Inc. Washing machine and method for controlling the same
AU2016234988B2 (en) 2015-10-02 2018-08-02 Lg Electronics Inc. Washing machine
US20170096769A1 (en) 2015-10-02 2017-04-06 Lg Electronics Inc. Method for controlling washing machine
US12351551B2 (en) * 2019-11-27 2025-07-08 Yonsung Fine Chemical Co., Ltd. Method for producing maxacalcitol, and intermediate therefor

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU688125A3 (ru) * 1974-12-09 1979-09-25 Тейдзин Лимитед (Фирма) Способ получени 1 , 24/ /диокси-холекальциферола или 1 , 24 / /-диоксихолекальциферола или их производных
EP0296800B1 (en) * 1987-06-23 1991-10-16 Yamanouchi Pharmaceutical Co. Ltd. Vitamin d3 derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9206648D0 (en) 1992-03-26 1992-05-06 Leo Pharm Prod Ltd Chemical compounds
GB9223061D0 (en) 1992-11-04 1992-12-16 Leo Pharm Prod Ltd Chemical compounds
US5552392A (en) 1993-11-03 1996-09-03 Wisconsin Alumni Research Foundation Method of treating hypoparathyroidism with (20S) vitamin D compounds

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU688125A3 (ru) * 1974-12-09 1979-09-25 Тейдзин Лимитед (Фирма) Способ получени 1 , 24/ /диокси-холекальциферола или 1 , 24 / /-диоксихолекальциферола или их производных
EP0296800B1 (en) * 1987-06-23 1991-10-16 Yamanouchi Pharmaceutical Co. Ltd. Vitamin d3 derivatives

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2560677C2 (ru) * 2009-12-22 2015-08-20 Лео Фарма А/С Кожная композиция, включающая аналог витамина d и смесь растворителя и поверхностно-активных веществ
RU2560184C2 (ru) * 2010-01-26 2015-08-20 Ибриженикс Са Новый способ изомеризации конденсированных бициклических структур и получение аналогов витамина d, содержащих эти структуры
RU2558362C2 (ru) * 2010-10-25 2015-08-10 Тейдзин Фарма Лимитед Производное 23-ин-витамина d3
RU2837000C2 (ru) * 2018-04-03 2025-03-25 Опко Айэлэнд Глобал Холдингз, Лтд. Применение кальцифедиола у пациентов, перенесших бариатрическую операцию

Also Published As

Publication number Publication date
EP0906276B1 (en) 2002-08-07
PL329941A1 (en) 1999-04-26
GB9611603D0 (en) 1996-08-07
CN1217926C (zh) 2005-09-07
RO120133B1 (ro) 2005-09-30
EP0906276A1 (en) 1999-04-07
WO1997046522A1 (en) 1997-12-11
DE69714590T2 (de) 2003-04-24
AU714223B2 (en) 1999-12-23
CZ296255B6 (cs) 2006-02-15
AU3025697A (en) 1998-01-05
ES2179343T3 (es) 2003-01-16
ATE221875T1 (de) 2002-08-15
CZ397198A3 (cs) 1999-03-17
JP2000511894A (ja) 2000-09-12
DE69714590D1 (de) 2002-09-12
PL186804B1 (pl) 2004-02-27
CN1219928A (zh) 1999-06-16
DK0906276T3 (da) 2002-12-02
HK1019733A1 (en) 2000-02-25
PT906276E (pt) 2002-12-31
NZ332237A (en) 2000-07-28
US6197982B1 (en) 2001-03-06

Similar Documents

Publication Publication Date Title
RU2114825C1 (ru) Производные витамина d
RU2037484C1 (ru) Аналог витамина д
KR100295977B1 (ko) 신규한비타민d동족체및이의제조방법
RU2196132C2 (ru) Аналоги витамина d, способы его получения, промежуточное соединение, фармацевтическая композиция
EP0906276B1 (en) Novel vitamin d analogues
US5401732A (en) Vitamin D analogues
RU2183622C2 (ru) Аналоги витамина d, способ их получения, фармацевтическая комопзиция
KR100548972B1 (ko) 비타민d동족체
JPH08501572A (ja) 新規ビタミンｄ類似体
RU2175318C2 (ru) Производные витамина d3, способы его получения, фармацевтическая композиция
WO1989010352A1 (en) SIDE CHAIN UNSATURATED 1alpha-HYDROXYVITAMIN D HOMOLOGS
RU2223953C2 (ru) Аналоги витамина D, фармацевтическая композиция, соединения
MX2007011919A (es) 2-metilen-19-nor-(23s)-25-deshidro-1a-hidroxivitamina d3-26,23-lactona y 2-metilen19-nor-(23r)-25-deshidro-1a- hidroxivitamina d3-26,23-lactona.
KR100494205B1 (ko) 신규한비타민d동족체
RU2261244C2 (ru) Новые аналоги витамина d
CA2254806A1 (en) Novel vitamin d analogues
JP2009511433A (ja) １９，２３，２４，２５，２６，２７−ヘキサノール−１α−ヒドロキシビタミンＤ３
MX2008009901A (en) Vitamin d analog - rak, methods and uses thereof

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20130516